Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma - Dutoit, Valérie; Herold-Mende, Christel (OncoImmunology, 2018)
Gesehen am 18.10.2018